173 related articles for article (PubMed ID: 31002127)
1. LncRNA SNHG1 promotes liver cancer development through inhibiting p53 expression via binding to DNMT1.
Li SJ; Wang L; Sun ZX; Sun SJ; Gao J; Ma RL
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(7):2768-2776. PubMed ID: 31002127
[TBL] [Abstract][Full Text] [Related]
2. LncRNA LINC00673 inhibits p53 expression by interacting with EZH2 and DNMT1 in papillary thyroid carcinoma.
Meng XF; Zhao LY; Chu XF
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2075-2083. PubMed ID: 30915752
[TBL] [Abstract][Full Text] [Related]
3. lncRNA HOXB-AS3 promotes hepatoma by inhibiting p53 expression.
Zhang XM; Chen H; Zhou B; Zhang QY; Liao Y; Wang JS; Wang ZH
Eur Rev Med Pharmacol Sci; 2018 Oct; 22(20):6784-6792. PubMed ID: 30402841
[TBL] [Abstract][Full Text] [Related]
4. LncRNA SNHG7 participates in osteosarcoma progression by down-regulating p53 via binding to DNMT1.
Zhang GD; Gai PZ; Liao GY; Li Y
Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3602-3610. PubMed ID: 31114984
[TBL] [Abstract][Full Text] [Related]
5. Long Noncoding RNA LINC00467 Promotes Glioma Progression through Inhibiting P53 Expression via Binding to DNMT1.
Zhang Y; Jiang X; Wu Z; Hu D; Jia J; Guo J; Tang T; Yao J; Liu H; Tang H
J Cancer; 2020; 11(10):2935-2944. PubMed ID: 32226508
[No Abstract] [Full Text] [Related]
6. Long noncoding RNA ATB participates in the development of renal cell carcinoma by downregulating p53 via binding to DNMT1.
Song C; Xiong Y; Liao W; Meng L; Yang S
J Cell Physiol; 2019 Aug; 234(8):12910-12917. PubMed ID: 30536843
[TBL] [Abstract][Full Text] [Related]
7. LncRNA SNHG1 promotes cell proliferation in laryngeal cancer via Notch1 signaling pathway.
Liu T; Zuo JJ; Li F; Xu YC; Zheng AY; Tao ZZ
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6562-6569. PubMed ID: 31378897
[TBL] [Abstract][Full Text] [Related]
8. LncRNA SNHG1 overexpression regulates the proliferation of acute myeloid leukemia cells through miR-488-5p/NUP205 axis.
Bao XL; Zhang L; Song WP
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5896-5903. PubMed ID: 31298340
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA GClnc1 promotes progression of colorectal cancer by inhibiting p53 signaling pathway.
Dong YX; Pang ZG; Zhang JC; Hu JQ; Wang LY
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5705-5713. PubMed ID: 31298323
[TBL] [Abstract][Full Text] [Related]
10. LINC01116 promotes proliferation, invasion and migration of osteosarcoma cells by silencing p53 and EZH2.
Zhang ZF; Xu HH; Hu WH; Hu TY; Wang XB
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6813-6823. PubMed ID: 31486480
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA (lncRNA) small nucleolar RNA host gene 1 (SNHG1) promote cell proliferation in colorectal cancer by affecting P53.
Zhao Y; Qin ZS; Feng Y; Tang XJ; Zhang T; Yang L
Eur Rev Med Pharmacol Sci; 2018 Feb; 22(4):976-984. PubMed ID: 29509245
[TBL] [Abstract][Full Text] [Related]
12. LncRNA-SNHG1 contributes to gastric cancer cell proliferation by regulating DNMT1.
Hu Y; Ma Z; He Y; Liu W; Su Y; Tang Z
Biochem Biophys Res Commun; 2017 Sep; 491(4):926-931. PubMed ID: 28754593
[TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA SNHG1 predicts a poor prognosis and promotes hepatocellular carcinoma tumorigenesis.
Zhang M; Wang W; Li T; Yu X; Zhu Y; Ding F; Li D; Yang T
Biomed Pharmacother; 2016 May; 80():73-79. PubMed ID: 27133041
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA SNHG1 functions as a competitive endogenous RNA to regulate PDCD4 expression by sponging miR-195-5p in hepatocellular carcinoma.
Huang D; Wei Y; Zhu J; Wang F
Gene; 2019 Sep; 714():143994. PubMed ID: 31330233
[TBL] [Abstract][Full Text] [Related]
15. Role of long non-coding RNA SNHG1 in occurrence and progression of ovarian carcinoma.
Ge J; Wu XM; Yang XT; Gao JM; Wang F; Ye KF
Eur Rev Med Pharmacol Sci; 2018 Jan; 22(2):329-335. PubMed ID: 29424921
[TBL] [Abstract][Full Text] [Related]
16. Up-regulation of long non-coding RNA SNHG1 contributes to proliferation and metastasis in laryngeal squamous cell carcinoma.
Lin SX; Jiang H; Xiang GZ; Zhang WR; Weng YH; Qiu FD; Wu J; Wang HG
Eur Rev Med Pharmacol Sci; 2018 Mar; 22(5):1333-1341. PubMed ID: 29565491
[TBL] [Abstract][Full Text] [Related]
17. LncRNA SAMD12-AS1 Promotes the Progression of Gastric Cancer via DNMT1/p53 Axis.
Lu GH; Zhao HM; Liu ZY; Cao Q; Shao RD; Sun G
Arch Med Res; 2021 Oct; 52(7):683-691. PubMed ID: 33962804
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of SNHG1 suppresses cell proliferation and invasion by regulating Notch signaling pathway in esophageal squamous cell cancer.
Zhang Y; Jin X; Wang Z; Zhang X; Liu S; Liu G
Cancer Biomark; 2017 Dec; 21(1):89-96. PubMed ID: 29081407
[TBL] [Abstract][Full Text] [Related]
19. LncRNA BC200 regulates the cell proliferation and cisplatin resistance in non-small cell lung cancer via PI3K/AKT pathway.
Gao BB; Wang SX
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1093-1101. PubMed ID: 30779077
[TBL] [Abstract][Full Text] [Related]
20. MEG3 promotes liver cancer by activating PI3K/AKT pathway through regulating AP1G1.
Sun Y; Cao FL; Qu LL; Wang ZM; Liu XY
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1459-1467. PubMed ID: 30840267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]